Back to Search
Start Over
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms.
- Source :
- American Journal of Hematology; Feb2018, Vol. 93 Issue 2, p277-285, 9p
- Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 03618609
- Volume :
- 93
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- American Journal of Hematology
- Publication Type :
- Academic Journal
- Accession number :
- 127166365
- Full Text :
- https://doi.org/10.1002/ajh.24972